Noritaka Tanaka
-
- Peptidase Inhibition and Analysis 2
-
- Cancer, Hypoxia, and Metabolism 6
-
- DNA Repair Mechanisms 2
- PI3K/AKT/mTOR signaling in cancer 2
-
- Hippo pathway signaling and YAP/TAZ 2
-
- Hepatocellular Carcinoma Treatment and Prognosis 2
- Liver physiology and pathology 2
-
- Immune cells in cancer 2
Noritaka Tanaka
27 papers receiving 608 citations
Hit Papers
Peers
Comparison fields: 5 of 60
- Oncology 187
- Cancer Research 98
- Molecular Biology 419
- Physiology 99
- Cell Biology 51
Countries citing papers authored by Noritaka Tanaka
This map shows the geographic impact of Noritaka Tanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noritaka Tanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noritaka Tanaka more than expected).
Fields of papers citing papers by Noritaka Tanaka
This network shows the impact of papers produced by Noritaka Tanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noritaka Tanaka. The network helps show where Noritaka Tanaka may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Noritaka Tanaka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 23 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 5 | |
| 4 | 2023 | 5 | |
| 5 | 2023 | 20 | |
| 6 | 2023 | 3 | |
| 7 | Clinical Acquired Resistance to KRASG12C Inhibition through a Novel KRAS Switch-II Pocket Mutation and Polyclonal Alterations Converging on RAS–MAPK Reactivationbreakdown → | 2021 | 302 |
| 8 | 2019 | 3 | |
| 9 | 2017 | 68 | |
| 10 | 2017 | 19 | |
| 11 | 2016 | 9 | |
| 12 | 2011 | 4 | |
| 13 | [Research on the correlation between DNA recombinational mutation and cancer malignancy in human colon cancers]. | 1994 | 1 |
| 14 | Discordant liver xenograft transplantation. | 1994 | 1 |
| 15 | 1989 | 6 | |
| 16 | Post-irradiation kinetics of the C3H/He mouse mammary carcinoma as regards tumor volume regrowth time and cell loss. | 1979 | 1 |
| 17 | Fundamental study of automatic cyto-screening for uterine cancer. II. Segmentation of cells and computer simulation. | 1977 | 6 |
| 18 | 1974 | 15 | |
| 19 | BIOLOGICAL STUDIES ON BACIMETHRIN, A PYRIMIDINE ANTIBIOTIC, AND MONAZOMYCIN. | 1963 | 4 |
| 20 | Biological studies on mikamycin. II. Laboratory investigations of mikamycin A and mikamycin B. | 1959 | 6 |
About Noritaka Tanaka
Noritaka Tanaka is a scholar working on Cancer Research, Hepatology and Cell Biology, having authored 28 papers that have together received 625 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (6 papers), DNA Repair Mechanisms (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Liver physiology and pathology (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Peptidase Inhibition and Analysis (2 papers), Hippo pathway signaling and YAP/TAZ (2 papers) and Immune cells in cancer (2 papers). The work is most often cited by research in Oncology (187 citations), Cancer Research (98 citations) and Molecular Biology (419 citations). Noritaka Tanaka has collaborated with scholars based in Japan and United States. Frequent co-authors include Tomoki Yamatsuji, Takashi Okamoto, Shuji Takeda, Ikuo Nishimoto, Yoshitake Murayama, Ryan B. Corcoran, Chendi Li, W. Marston Linehan, Lesli A. Kiedrowski and Aaron N. Hata. Their work appears in journals such as Cancer Science, Cancer Discovery, Molecular Cancer Therapeutics, JNCI Journal of the National Cancer Institute and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.